Skip to main content
Erschienen in: Current Diabetes Reports 12/2019

01.12.2019 | Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors)

Technological Advancements in the Management of Type 2 Diabetes

verfasst von: Abigail Kennedy Grant, Lauren Golden

Erschienen in: Current Diabetes Reports | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The increasing prevalence of type 2 diabetes is driving the boundaries of clinical diabetes care outside of the traditional office setting. The purpose of this paper will be to review recent technological advances in the medical management of people with type 2 diabetes, spanning the spectrum of care from access to healthcare providers/educators, to continual virtual support methods, on-line management tools, and technologically integrated medication delivery systems.

Recent Findings

Recent findings support a potential positive impact of technology on access to care, clinical outcomes, convenience, patient well-being, and patient acceptance. This includes the use of Bluetooth-enabled glucose meters, continuous glucose monitors, mHealth apps, smartpens, and insulin pumps. However, there are impediments to the implementation of some technologies due to cost and lack of insurance coverage.

Summary

There is evidence to support the use of technology to improve the management and treatment of people with type 2 diabetes. Further research is required to demonstrate the long-term clinical benefit and financial viability of technology in the management of type 2 diabetes.
Literatur
1.
Zurück zum Zitat National diabetes statistics report, 2017. Atlanta, GA, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, 2017. National diabetes statistics report, 2017. Atlanta, GA, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, 2017.
3.
Zurück zum Zitat Glasgow RE, Kurz D, King D, Dickman JM, Faber AJ, Halterman E, et al. Twelve-month outcomes of an internet-based diabetes self-management support program. Patient Educ Couns. 2012 Apr;87(1):81–92.CrossRef Glasgow RE, Kurz D, King D, Dickman JM, Faber AJ, Halterman E, et al. Twelve-month outcomes of an internet-based diabetes self-management support program. Patient Educ Couns. 2012 Apr;87(1):81–92.CrossRef
5.
Zurück zum Zitat Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8(1):55–73.CrossRef Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8(1):55–73.CrossRef
6.
Zurück zum Zitat •• Beck RW, Riddlesworth TD, Ruedy K, Ahmann A, Haller S, Kruger D, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med. [Epub ahead of print 22 August 2017] 167:365–374. doi: https://doi.org/10.7326/M16-2855. Many studies have demonstrated improved glycemic control in subjects with type 1 diabetes using continuous glucose monitoring. Few studies have evaluated the impact and acceptability of CGM in people living with type 2 diabetes. This study demonstrates that CGM can improve glycemic control in adults with type 2 diabetes and that use of CGM was associated with a high degree of patient satisfaction. CrossRef •• Beck RW, Riddlesworth TD, Ruedy K, Ahmann A, Haller S, Kruger D, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med. [Epub ahead of print 22 August 2017] 167:365–374. doi: https://​doi.​org/​10.​7326/​M16-2855. Many studies have demonstrated improved glycemic control in subjects with type 1 diabetes using continuous glucose monitoring. Few studies have evaluated the impact and acceptability of CGM in people living with type 2 diabetes. This study demonstrates that CGM can improve glycemic control in adults with type 2 diabetes and that use of CGM was associated with a high degree of patient satisfaction. CrossRef
8.
Zurück zum Zitat Raval AD, Nguyen MH, Zhou S, Grabner M, Barron J, Quimbo R. Effect of V-Go versus multiple daily injections on glycemic control, insulin use, and diabetes medication costs among individuals with type 2 diabetes mellitus. J Manag Care Spec Pharm. 2019;5:1–14. https://doi.org/10.18553/jmcp.2019.18438. Raval AD, Nguyen MH, Zhou S, Grabner M, Barron J, Quimbo R. Effect of V-Go versus multiple daily injections on glycemic control, insulin use, and diabetes medication costs among individuals with type 2 diabetes mellitus. J Manag Care Spec Pharm. 2019;5:1–14. https://​doi.​org/​10.​18553/​jmcp.​2019.​18438.
9.
Zurück zum Zitat Aronson R, Reznik Y, Conget I, Castañeda JA, Runzis S, Lee SW, et al. Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial. Diabetes Obes Metab. 2016;18(5):500–7. https://doi.org/10.1111/dom.12642.CrossRef Aronson R, Reznik Y, Conget I, Castañeda JA, Runzis S, Lee SW, et al. Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial. Diabetes Obes Metab. 2016;18(5):500–7. https://​doi.​org/​10.​1111/​dom.​12642.CrossRef
10.
Zurück zum Zitat • Wang Y, Xue H, Huang Y, Huang L, Zhang D. A systematic review of application and effectiveness of mHealth interventions for obesity and diabetes treatment and self-management. Adv Nutr. 2017;8(3):449–462. Published 2017 May 15. doi:https://doi.org/10.3945/an.116.014100. This study reviews the effects of mHealth interventions for management and treatment of obesity and type 2 diabetes. While preliminary evidence is promising, more studies with larger sample sizes and long-term outcomes are needed. CrossRef • Wang Y, Xue H, Huang Y, Huang L, Zhang D. A systematic review of application and effectiveness of mHealth interventions for obesity and diabetes treatment and self-management. Adv Nutr. 2017;8(3):449–462. Published 2017 May 15. doi:https://​doi.​org/​10.​3945/​an.​116.​014100. This study reviews the effects of mHealth interventions for management and treatment of obesity and type 2 diabetes. While preliminary evidence is promising, more studies with larger sample sizes and long-term outcomes are needed. CrossRef
Metadaten
Titel
Technological Advancements in the Management of Type 2 Diabetes
verfasst von
Abigail Kennedy Grant
Lauren Golden
Publikationsdatum
01.12.2019
Verlag
Springer US
Erschienen in
Current Diabetes Reports / Ausgabe 12/2019
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-019-1278-3

Weitere Artikel der Ausgabe 12/2019

Current Diabetes Reports 12/2019 Zur Ausgabe

Therapies and New Technologies in the Treatment of Diabetes (M Pietropaolo, Section Editor)

The Use of Non-insulin Agents in Gestational Diabetes: Clinical Considerations in Tailoring Therapy

Pathogenesis of Type 1 Diabetes (A Pugliese and SJ Richardson, Section Editors)

What the HLA-I!—Classical and Non-classical HLA Class I and Their Potential Roles in Type 1 Diabetes

Diabetes and Pregnancy (M-F Hivert and CE Powe, Section Editors)

Hyperglycemia During Pregnancy and Long-Term Offspring Outcomes

Health Care Delivery Systems and Implementation in Diabetes (ME McDonnell and AR Sadhu, Section Editors)

mHealth Interventions for Disadvantaged and Vulnerable People with Type 2 Diabetes

Macrovascular Complications in Diabetes (VR Aroda and A Getaneh, Section Editors)

Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at “Extreme” ASCVD Risk

Pathogenesis of Type 1 Diabetes (A Pugliese and SJ Richardson, Section Editors)

Human Endogenous Retroviruses and Type 1 Diabetes

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.